TAK-165

TAK-165 · Takeda Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-165, covering 2012-02-02 to 2012-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 [Phase 1]